RXi Pharmaceuticals Corp (RXII)

0.69
NASDAQ : Health Care
Prev Close 0.69
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.60 / 3.27
Avg Volume 880.90K
Exchange NASDAQ
Shares Outstanding 13.15M
Market Cap 9.20M
EPS -2.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

RXi Pharmaceuticals Completes Acquisition Of MirImmune Inc. And Appoints New Chief Business Officer

RXi Pharmaceuticals Completes Acquisition Of MirImmune Inc. And Appoints New Chief Business Officer

Acquisition expands RXi's pipeline to include cell-based immunotherapy to treat cancer

RXi Pharmaceuticals Enters Into Exclusive Option Agreement To Acquire MirImmune Inc.

RXi Pharmaceuticals Enters Into Exclusive Option Agreement To Acquire MirImmune Inc.

Acquisition will broaden RXi's pipeline to include immuno-oncology with the use of the Company's proprietary sd-rxRNA® platform

RXi Pharmaceuticals Corporation Selected to Present at Cavendish Global Health Impact Forum

RXi Pharmaceuticals Corporation Selected to Present at Cavendish Global Health Impact Forum

Forum uniquely brings together leading family offices, foundations and impact investors seeking impact investment, grant-giving, and philanthropy opportunities within health and life sciences